Michael Ressner - Magellan Health Independent Director

Director

Mr. Michael P. Ressner is an Independent Director of the Company, since January 5, 2004. He retired from Nortel Networks, where between 1981 and 2003 he was a senior executive with functional responsibilities that spanned the areas of finance and general management including vice presidentfinance. Mr. Ressner was an adjunct professor of finance and accounting at the North Carolina State University College of Management between 2003 and 2005. He now sits on the advisory board of the Enterprise Risk Management Institute at North Carolina State University. Mr. Ressner currently serves on the board of directors and audit and compensation committees of Exide Technologies, a NASDAQlisted stored electrical energy solution company, and within the previous five years served on the boards of Entrust, Inc., a publiclytraded information security company, Tekelec, a NASDAQlisted provider of network signaling systems, and Arsenal Digital Solutions, a privatelyheld data storage services company. As a member of the Executive Service Corporationration, Mr. Ressner participates in assignments that focus on providing financial management and governance consultancy to notforprofit organizations in the RaleighDurhamChapel Hill area. Mr. Ressner was last nominated for reelection as a director in 2013 due to his financial and accounting experience, and his favorable record serving as a director since 2004. since 2004.
Age 66
Tenure 20 years
Phone800 642-1716
Webwww.magellanhealth.com

Magellan Health Management Efficiency

The company has return on total asset (ROA) of 0.54 % which means that it generated a profit of $0.54 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health's management efficiency ratios could be used to measure how well Magellan Health manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 562.64 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Magellan Health has a current ratio of 2.86, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Magellan Health until it has trouble settling it off, either with new capital or with free cash flow. So, Magellan Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Magellan Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Magellan to invest in growth at high rates of return. When we think about Magellan Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Genevieve BergerLAir Liquide SA
63
Susan LiAlaska Air Group
35
Paul SkinnerLAir Liquide SA
70
Daniel HanrahanCedar Fair LP
62
Julie SchneeklothUnited Fire Group
N/A
Sin LowLAir Liquide SA
66
Marion BlakeyAlaska Air Group
72
Gregory ShareKinsale Capital Group
46
Frederick RussellKinsale Capital Group
60
Cornelis LedeLAir Liquide SA
72
Billie WilliamsonPentair PLC
68
Francois JackowLAir Liquide SA
54
Douglas HultquistUnited Fire Group
58
Steven BensingerKinsale Capital Group
65
James RitchieKinsale Capital Group
65
Casey MahonUnited Fire Group
63
Jerry BurrisPentair PLC
52
Kenneth ThompsonAlaska Air Group
63
Thierry DesmarestLAir Liquide SA
70
Pierre DufourLAir Liquide SA
63
Joel KillionKinsale Capital Group
39
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation. Magellan Health operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 9000 people. Magellan Health (MGLN) is traded on NASDAQ Exchange in USA and employs 9,000 people.

Management Performance

Magellan Health Leadership Team

Elected by the shareholders, the Magellan Health's board of directors comprises two types of representatives: Magellan Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Magellan. The board's role is to monitor Magellan Health's management team and ensure that shareholders' interests are well served. Magellan Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Magellan Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eran Broshy, Independent Director
Swati Abbott, Director
Mostafa Kamal, Senior Vice President and General Manager
Scott MacKenzie, Independent Director
Barry Smith, Chairman and CEO
Mary Sammons, Independent Director
Joe Bogdan, Senior Vice President Corporate Finance
Steven Shulman, Independent Director
Matthew Simas, Director
Perry Fine, Independent Director
Daniel Gregoire, General Counsel and Secretary
Kay James, Director
Srinivas Koushik, CTO
Leslie Norwalk, Independent Director
John Agwunobi, Independent Director
John Littel, Senior Vice President - Government Affairs and Communications
Michael Diament, Independent Director
William McBride, Independent Director
Guy Sansone, Independent Director
Peter Feld, Independent Director
Renie Shapiro, Senior Vice President Corporate Finance
Michael Ressner, Independent Director
Sanjeev Srivastava, CEO of Magellan Healthcare
Caskie LewisClapper, Chief Human Resource Officer

Magellan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Magellan Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Magellan Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Magellan Health's short interest history, or implied volatility extrapolated from Magellan Health options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Magellan Stock

If you are still planning to invest in Magellan Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magellan Health's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges